https://www.news-medical.net/news/20230122/Phase-I-trial-results-from-AdaptVacs-COVID-capsid-virus-like-particle-vaccine.aspx
0
0
42 words
0
Comments
In a recent study published in The Lancet Microbe journal, researchers described the effectiveness of a modular capsid virus-like coronavirus disease 2019 (COVID-19) vaccination.
You are the first to view
Create an account or login to join the discussion